CCND1 and endometrial cancer: The majority of CCND1-mutated endometrial cancer cases (70%, 21 of 30 endometrial cancers, Tables 3 and 4) contained mutations in the c-terminus of cyclin D1 that may be implicated in cyclin D1 activation and gain-of-function (Tables 3 and 4).